Patents by Inventor Yoshimoto Nakashima

Yoshimoto Nakashima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5347012
    Abstract: A naphthothiopyranone derivative represented by the formula: ##STR1## (wherein R.sup.1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms) and an acid addition salt thereof have more excellent antagonist effect at serotonin 3 receptors than the prior art compounds and the effects based thereon, e.g. anti-vomiting effect, gastrointestinal movement regulating effect and anti-anxiety effect.
    Type: Grant
    Filed: December 11, 1992
    Date of Patent: September 13, 1994
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Tatsuhiko Sano, Keiko Saijo, Sadakazu Yokomori, Yoshimoto Nakashima, Katsuo Hatayama
  • Patent number: 5089654
    Abstract: Chalcone derivatives represented by the formula ##STR1## wherein R.sup.1 is a straight chain, branched chain or cyclic alkyl group having 4 to 15 carbon atoms or an alkenyl group having 3 to 15 carbon atoms, and occurs at the 2- or 4-position, R.sup.2 is a hydrogen atom, a straight or branched chain alkyl group having 1 to 3 carbon atoms, and X is a straight or branched chain alkylene group having 1 to 3 carbon atoms, are disclosed. These compounds have anti-ulcer effect, gastric mucosal protection effect and antisecretory effect.
    Type: Grant
    Filed: August 3, 1990
    Date of Patent: February 18, 1992
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Sadakazu Yokomori, Keiko Saijo, Tohru Matsunaga, Yoshimoto Nakashima, Katsuo Hatayama
  • Patent number: 4980474
    Abstract: An apovincaminic acid derivative represented by the formula ##STR1## wherein n is an integer of from 2 to 11, and a pharmaceutically acceptable salt thereof are disclosed. These compounds are useful for therapy of cerebrovascular injuries, peripheral vessel injuries, angina pectoris, hypertension and senile dementia.
    Type: Grant
    Filed: September 12, 1989
    Date of Patent: December 25, 1990
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Masatoshi Hayashi, Sadakazu Yokomori, Yoshimoto Nakashima, Katsuo Hatayama
  • Patent number: 4883876
    Abstract: Vincaminic acid derivatives represented by the formula ##STR1## wherein R.sup.1 is a hydrogen atom, an alkyl group having 1 to 8 carbon atoms or an alkoxyalkyl group having 2 to 6 carbon atoms, R.sup.2 is a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 5 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, an alkoxycarbonylallyl group having 3 to 8 carbon atoms, an alkenyl group having 2 to 4 carbon atoms, a phenyl group, a phenyl group substituted by alkoxy groups each having 1 or 2 carbon atoms or a thienyl group, A is a hydroxy group, B is a hydrogen atom, or A and B together form a valence bond, and the acid addition salts thereof are disclosed. These compound are useful as thereapeutic effect on cerebovascular injuries.
    Type: Grant
    Filed: September 2, 1988
    Date of Patent: November 28, 1989
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Shin-ichi Nakatsuka, Masatoshi Hayashi, Sadakazu Yokomori, Yoshimoto Nakashima, Katsuo Hatayama, Hiroaki Araki
  • Patent number: 4803266
    Abstract: 2-Azetidione derivatives represented by the following formula ##STR1## wherein X is a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a hydroxyl group or a cyano group, l is 1 or 2, R.sup.1 is a lower alkyl group, a cycloalkyl group, a 1-naphthylmethyl group, an optionally substituted phenethyl group, an optionally substituted phenyl group, an optionally substituted benzyl group or a bis(alkoxycarbonyl)ethyl group, and R.sup.2 is a lower alkyl group, a lower alkoxy group, an amino group, an adamantyl group, a lower alkoxycarbonylmethyl group or an optionally substituted phenyl group, are disclosed. These compounds are useful as blood platelet aggregation inhibiting agents.
    Type: Grant
    Filed: October 5, 1987
    Date of Patent: February 7, 1989
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Yutaka Kawashima, Masakazu Satoh, Yuichi Hatada, Fumiko Hazato, Yoshimoto Nakashima, Kaoru Sota
  • Patent number: 4730052
    Abstract: Unsymmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid diesters represented by the general formula ##STR1## wherein R.sup.1 and R.sup.2 are different and represent each a nitratoalkyl having 2 or 3 carbon atoms, are prepared from the corresponding acid monoester in the presence of an organic acid anhydride activating agent. These compounds are useful as therapeutic agents for cardiovascular disorders.
    Type: Grant
    Filed: July 9, 1985
    Date of Patent: March 8, 1988
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Yoshimoto Nakashima, Toshihisa Ogawa, Atsuro Nakazato, Yukinari Kumazawa, Kaoru Sota
  • Patent number: 4594197
    Abstract: 3-Benzoyl-2-mercaptopropionic acid derivatives represented by the general formula ##STR1## (wherein, X represents a hydrogen atom, a halogen atom, hydroxy group, a lower alkyl group or a lower alkoxy group, Y represents a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, Z represents a hydrogen atom or an acyl group, and R represents a hydrogen atom or a lower alkyl group). These compounds have immunomodulative function and are effective for the treatment of diseases caused by abnormal immunofunction.
    Type: Grant
    Filed: August 31, 1984
    Date of Patent: June 10, 1986
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Kazuyuki Tomisawa, Kazuya Kameo, Toru Matsunaga, Shiuji Saito, Yoshimoto Nakashima, Kaoru Sota
  • Patent number: 4541959
    Abstract: Diphenylsulfide derivatives represented by the general formula ##STR1## wherein, X represents a hydrogen atom, a chlorine atom or a methyl group, and R represents a hydrogen atom or a lower alkyl group. These diphenyl sulfides reduce lipids such as cholesterols and triglycerides in the blood of mammals.
    Type: Grant
    Filed: August 29, 1984
    Date of Patent: September 17, 1985
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Kazuyuki Tomisawa, Kazuya Kameo, Toru Matsunaga, Shiuji Saito, Yoshimoto Nakashima, Kaoru Sata